BioNTech-Pfizer COVID-19 vaccine

US Food and Drug Administration (FDA) on Wednesday authorised Pfizer’s antiviral pill, Paxlovid to treat COVID-19 in high-risk people aged 12 and over, a major milestone in the pandemic that will allow millions to access the treatment.…

BioNTech-Pfizer has on Wednesday said their vaccine showed 100 percent efficacy against the coronavirus in 12 to 15 year olds, as they eye approval for adolescents to get the jabs before the next school year. Phase 3 trials carried…